Bleeding disorders associated with cancer dysproteinemias.
Zangari
Maurizio
M
University of Utah, Division of Hematology, Blood/Marrow Transplant and Myeloma Program, Salt Lake City, UT, USA. maurizio.zangari@hsc.utah.edu
Elice
F
F
Tricot
G
G
Fink
L
L
D000686:Amyloidosis / Q000097:blood / Q000150:complications; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000502:physiology; D005342:Fibrinolysis; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006474:Hemorrhagic Disorders / Q000097:blood / Q000209:etiology* / Q000628:therapy; D006489:Hemostatic Techniques; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D010265:Paraproteinemias / Q000097:blood* / Q000209:etiology; D010951:Plasma Exchange; D051381:Rats; D013921:Thrombocytopenia / Q000209:etiology; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000150:complications
D020533:Angiogenesis Inhibitors; D001779:Blood Coagulation Factors